Proteome, secretome, kinome… What’s it all about?

Proteome is referenced as the result of expression of the whole genome. With the recent developments of genomics, one could consider that this analysis is enough to decipher any biological mechanism…
But depending on your sample, some regulations occur, that are not directly linked to the genes: isoform splicing, post-translational modifications (such as phosphorylation, acetylation & glycosylation), secretion…

Genomics, although powerful, does not allow the analysis of such protein-specific modifications. To overcome these limits, proteomics emerges, with specific subsets having specific requirements. Here, I’d like to put the Secretome and Kinome in the highlight!

Secretome & Kinome: the trendy proteome subsets!

Secretome represents the proteins that are secreted from cells: messengers as cytokines, chemokines, growth factors… But also soluble receptors or extracellular matrix proteins. Their secretion is strictly regulated, and they are considered inactive as long as they are not released in the extra-cellular environment, or the circulation.

Kinome represents a set of kinases involved in cellular signaling pathway activation. The phosphorylation status of a protein is a key factor to determine its activity status.  Thus, the activation level of a transduction pathway can be estimated by evaluating the phosphorylation level of its proteins.

Updated version of the AKT cell signaling pathway Rockland Inc. tebu-bio

Kinome in the AKT cell signaling pathway

Why are Secretome and Kinome such hot topics?

These proteome subsets have various applications. Secretome and Kinome have already been used in:

  • Fundamental research – To understanding biological mechanisms
  • Pharmaceutic industry – To identify new therapeutic targets
  • Diagnostics/pronostics – To define new biomarkers
  • Personalized medicine – To discover biomarker showing the efficiency of a drug, or allowing to classify each patient in a cohort that will receive a specific treatment…

The secretome used to be the immunologist’s favourite subject, but more topics have recently been raised, such as cancer research with the study of the communication between cancer cells and their environment (1) or propagation of metastatic cells (2).

Secretome biomarkers are especially interesting since they can be isolated from blood (more accessible, less intrusive than biopsies…)

What about Kinome? The kinome biomarkers might be the ones to find out when considering cancer cell growth deregulation. In this case, it is no more the expression or the secretion of a protein, but its phosphorylation level, which becomes the target/biomarker. (3)

Are you a Kinome or Secretome fan?

Contact us to discover how we can help you to identify new markers!


(1) Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2 (Angela Schulz et al., Haematologica, March 2011 96:408-416)

(2) Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis (Jin L et al., Cell Res. 2012 Sep;22(9):1356-73)

(3) Defining the expressed breast cancer kinome (Alicia A Midland et al, Cell Research (2012) 22:620–623)


  1. […] a previous post, I mentioned that the secretome is becoming a very hot topic in the world of proteome analysis, and even a crucial study subject. […]

  2. […] patient samples is preferable (be it ELISA kits (ex. Human CT-1 or HA), Antibody arrays,  secretome or kinome testings…).  The decision to pool biological samples before performing the experimental […]

  3. […] One approach is to measure global glycosylation levels with a lectin based array. This array allows for simultaneous measurements of the levels of 40 lectins which bind specifically to certain glycosylation patterns. Therefore, lectin arrays allow, for the semi-quantitative analysis of lectin-glycoprotein interactions present in any sample. For example, measuring the glycosylation patterns between a primary and a cancer cell’s conditioned media may elucidate potential changes in the overall glycosylation patterns in these cell’s secretome. […]

  4. […] trend nowadays is to run profiling projects, allowing to discover new biomarkers. This may mean that, for some of these new markers, ready-to-use ELISAs are not […]

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: